TickerFacts.

Galmed Pharmaceuticals Ltd. (EOCN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2023-08-09; 1-for-12, first reflected in a filing dated 2025-04-02; 1-for-8, first reflected in a filing dated 2026-09-02. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

4.31M
Year ended 2025-12-31
+213.7%
3-year compound annual growth
21.28M2019-12-31: 21.11M2020-12-31: 21.28M2021-12-31: 1.64M2022-12-31: 139.7K2023-12-31: 230.8K2024-12-31: 930.8K2025-12-31: 4.31M4.31M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-314.31M+363.2%2026-03-31, From 2025-01-01
2024-12-31930.8K+303.3%2026-03-31, From 2024-01-01
2023-12-31230.8K+65.2%2026-03-31, From 2023-01-01
2022-12-31139.7Kn/c2025-04-02, From 2022-01-01
2021-12-311.64Mn/c2024-04-04, From 2021-01-01
2020-12-3121.28M+0.8%2023-03-29, From 2020-01-01
2019-12-3121.11Mn/a2022-05-02, From 2019-01-01